S A Kharitonov

Author PubWeight™ 65.34‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma. Thorax 1998 2.71
2 Exhaled carbon monoxide in childhood asthma. J Pediatr 1999 2.19
3 Exhaled 8-isoprostane as an in vivo biomarker of lung oxidative stress in patients with COPD and healthy smokers. Am J Respir Crit Care Med 2000 2.03
4 Increased 8-isoprostane, a marker of oxidative stress, in exhaled condensate of asthma patients. Am J Respir Crit Care Med 1999 1.92
5 Supplementary oxygen in healthy subjects and those with COPD increases oxidative stress and airway inflammation. Thorax 2004 1.68
6 Exhaled nitric oxide: a new lung function test. Thorax 1996 1.64
7 Raised levels of exhaled carbon monoxide are associated with an increased expression of heme oxygenase-1 in airway macrophages in asthma: a new marker of oxidative stress. Thorax 1998 1.63
8 Exhaled nitric oxide in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998 1.60
9 Exhaled carbon monoxide and nitric oxide in COPD. Chest 2001 1.58
10 Exhaled leukotrienes and prostaglandins in COPD. Thorax 2003 1.55
11 Effects of cyclo-oxygenase inhibition on exhaled eicosanoids in patients with COPD. Thorax 2005 1.50
12 Effect of a nitric oxide synthase inhibitor and a glucocorticosteroid on exhaled nitric oxide. Am J Respir Crit Care Med 1995 1.47
13 Adenosine 5'-monophosphate increases levels of leukotrienes in breath condensate in asthma. Respir Med 2004 1.43
14 Slower rise of exhaled breath temperature in chronic obstructive pulmonary disease. Eur Respir J 2003 1.42
15 Increased nitrosothiols in exhaled breath condensate in inflammatory airway diseases. Am J Respir Crit Care Med 2001 1.41
16 Combined use of exhaled hydrogen peroxide and nitric oxide in monitoring asthma. Am J Respir Crit Care Med 1998 1.34
17 Increased nitrotyrosine in exhaled breath condensate of patients with asthma. Am J Respir Crit Care Med 2000 1.32
18 Increase in exhaled nitric oxide levels in patients with difficult asthma and correlation with symptoms and disease severity despite treatment with oral and inhaled corticosteroids. Asthma and Allergy Group. Thorax 1998 1.27
19 Exhaled nitric oxide from lung periphery is increased in COPD. Eur Respir J 2005 1.24
20 Increased leukotriene B4 and 8-isoprostane in exhaled breath condensate of patients with exacerbations of COPD. Thorax 2003 1.23
21 Exhaled ethane, a marker of lipid peroxidation, is elevated in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000 1.21
22 Increased nitric oxide metabolites in exhaled breath condensate after exposure to tobacco smoke. Thorax 2001 1.21
23 Effect of inhaled endotoxin on induced sputum in normal, atopic, and atopic asthmatic subjects. Thorax 1998 1.20
24 Nasal nitric oxide measurements for the screening of primary ciliary dyskinesia. Eur Respir J 2003 1.19
25 Increased inflammatory markers in the exhaled breath condensate of cigarette smokers. Eur Respir J 2003 1.16
26 Exhaled 8-isoprostane as a new non-invasive biomarker of oxidative stress in cystic fibrosis. Thorax 2000 1.08
27 8-Isoprostane as a biomarker of oxidative stress in interstitial lung diseases. Am J Respir Crit Care Med 1998 1.07
28 Elevation of exhaled ethane concentration in asthma. Am J Respir Crit Care Med 2000 1.05
29 Exhaled carbon monoxide levels elevated in diabetes and correlated with glucose concentration in blood: a new test for monitoring the disease? Chest 1999 1.05
30 Exhalation flow and pressure-controlled reservoir collection of exhaled nitric oxide for remote and delayed analysis. Thorax 1998 1.04
31 Endogenous nitric oxide is decreased in asthmatic patients by an inhibitor of inducible nitric oxide synthase. Am J Respir Crit Care Med 1996 1.02
32 Effect of short- and long-acting inhaled beta2-agonists on exhaled nitric oxide in asthmatic patients. Eur Respir J 1997 1.01
33 An inhaled glucocorticoid does not prevent tolerance to the bronchoprotective effect of a long-acting inhaled beta 2-agonist. Am J Respir Crit Care Med 1996 1.01
34 Changes in exhaled carbon monoxide and nitric oxide levels following allergen challenge in patients with asthma. Eur Respir J 1999 1.01
35 Effect of inhaled L-arginine on exhaled nitric oxide in normal and asthmatic subjects. Thorax 1998 1.00
36 Increased levels of exhaled carbon monoxide in bronchiectasis: a new marker of oxidative stress. Thorax 1998 0.99
37 Increase in exhaled carbon monoxide during exacerbations of cystic fibrosis. Thorax 2000 0.98
38 The effect of alcohol ingestion on exhaled nitric oxide. Eur Respir J 1996 0.97
39 Nasal and exhaled nitric oxide is reduced in adult patients with cystic fibrosis and does not correlate with cystic fibrosis genotype. Chest 2000 0.96
40 Increased nitrotyrosine in exhaled breath condensate in cystic fibrosis. Eur Respir J 2001 0.95
41 Comparison of exhaled and nasal nitric oxide and exhaled carbon monoxide levels in bronchiectatic patients with and without primary ciliary dyskinesia. Thorax 2003 0.95
42 Increased carbon monoxide in exhaled air of patients with cystic fibrosis. Thorax 1999 0.94
43 Exhaled carbon monoxide in patients with lower respiratory tract infection. Respir Med 2001 0.93
44 Exhaled nitric oxide is increased in active fibrosing alveolitis. Chest 1999 0.93
45 Real-time measurement of particulate matter deposition in the lung. Biomarkers 2006 0.87
46 Intranasal administration of eotaxin increases nasal eosinophils and nitric oxide in patients with allergic rhinitis. J Allergy Clin Immunol 2000 0.87
47 Does exhaled nitric oxide reflect asthma control? Yes, it does! Am J Respir Crit Care Med 2001 0.84
48 Increased vitronectin and endothelin-1 in the breath condensate of patients with fibrosing lung disease. Respiration 2003 0.84
49 Exhaled and nasal nitric oxide is increased in laboratory animal allergy. Clin Exp Allergy 1998 0.83
50 Exhaled ethane is elevated in cystic fibrosis and correlates with carbon monoxide levels and airway obstruction. Am J Respir Crit Care Med 2000 0.80
51 Exhaled carbon monoxide in lung disease. Eur Respir J 2003 0.77
52 Local vasodilator response to mobile phones. Laryngoscope 2001 0.77
53 Direct methods for the measurement of nitric oxide. Monaldi Arch Chest Dis 2001 0.76
54 Feasibility and interpretation of FE(NO) measurements in asthma patients in general practice. Respir Med 2008 0.75
55 Exhaled breath temperature in asthma. Eur Respir J 2003 0.75
56 [Hyperbaric oxygenation in the treatment of dust bronchitis in coal miners]. Gig Tr Prof Zabol 1983 0.75
57 [Effect of hyperbaric oxygenation on central hemodynamics and oxygenating function of the lungs in open-heart surgery]. Fiziol Zh 1992 0.75
58 Measurement of exhaled hydrocarbons. Methods Mol Med 2001 0.75
59 [Pachydermoperiostosis syndrome]. Klin Med (Mosk) 1986 0.75
60 [Use of hyperbaric oxygenation the treatment of Lyell's syndrome]. Vrach Delo 1984 0.75
61 [Bettolepsy (cough-cerebral syndrome) in the clinical picture of occupational diseases]. Ter Arkh 1986 0.75
62 [Experimental-clinical substantiation of treatment with hyperbaric oxygenation of patients with dust-induced bronchitis]. Vrach Delo 1985 0.75
63 [Effect of hyperbaric oxygenation on the exercise tolerance of patients with dust-induced bronchitis]. Sov Med 1984 0.75